Blackhill Capital Inc. cut its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 33.7% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 177,930 shares of the healthcare product maker's